Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis
Read Article
News
2024
2023
Archive
Search news articles
September 14, 2009
WILDCAT DISCOVERY TECHNOLOGIES SELECTED BY ALWAYSON AS A GOINGGREEN TOP 100 WINNER
September 14, 2009
ACHAOGEN ANNOUNCES ACHN-490 CLINICAL DATA AT THE 49TH ANNUAL ICAAC MEETING
August 25, 2009
ACHAOGEN APPOINTS JOHN C. DOYLE TO THE NEWLY CREATED POSITION OF CHIEF OPERATING OFFICER
August 10, 2009
IKARIA TO IN-LICENSE WORLDWIDE RIGHTS TO INVESTIGATIONAL PORTFOLIO FROM FIBREX MEDICAL
July 6, 2009
IKARIA TO IN-LICENSE BIOLINERX’S BL-1040
June 12, 2009
FDA ACCEPTS FINAL SECTION OF NDA FILING FOR LUCASSIN®
June 1, 2009
ENTREMED PRESENTS RESULTS OF ENMD-2076 PHASE 1 STUDY IN ADVANCED CANCER PATIENTS
May 16, 2009
ACHAOGEN DATA SHOW RAPID RISE IN RATES OF RESISTANCE TO CURRENT ANTIBIOTICS; ILLUSTRATE GLOBAL NEED FOR NEW, WELL-TOLERATED AGENTS TO ADDRESS VARIED MECHANISMS OF RESISTANCE
May 13, 2009
SYNOSIA THERAPEUTICS BEGINS PHASE I TRIAL OF A NEW GENERATION TREATMENT FOR COGNITIVE IMPAIRMENT
May 1, 2009
PULMATRIX ANNOUNCES PH 1B/2A CLINICAL TRIAL OF NOVEL ICALM THERAPY FOR FLU
« Previous Page
1
…
100
101
102
103